How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Adults' Vitamin Tablets Market
- By Product Form: Tablet, Capsule, Softgel, Chewable Tablet, Effervescent Tablet
- By Vitamin Type: Multivitamins, Vitamin D, Vitamin C, Vitamin B Complex, Vitamin E, Vitamin A
- By Target Consumer: Men, Women, Seniors, Pregnant Women, Athletes
- By Distribution Channel: Pharmacies, Supermarkets/Hypermarkets, Online Retail, Specialty Stores, Direct Sales
- By Price Range: Economy, Mid-Range, Premium
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Tablet leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Adults' Vitamin Tablets Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Form 5
Vitamin Type 6
Target Consumer 5
Distribution Channel 5
Price Range 3
Companies profiled
Bayer AG
Pfizer Inc.
Nature's Bounty Co.
GNC Holdings Inc.
Amway Corporation
Herbalife Nutrition Ltd.
Abbott Laboratories
Nestlé S.A.
GlaxoSmithKline plc
Church & Dwight Co. Inc.
Jamieson Wellness Inc.
NOW Foods
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Pfizer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nature's Bounty Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →GNC Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Amway Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Herbalife Nutrition Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Abbott Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nestlé S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →GlaxoSmithKline plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Church & Dwight Co. Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Jamieson Wellness Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →NOW Foods
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Solgar Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Swisse Wellness
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Blackmores Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,850M by 2033 · 6.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Tablet42.7
- Capsule19.3
- Softgel17.9
- Chewable Tablet10.7
- Effervescent Tablet9.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$978.2M → $1,648M · 6.7%
Europe$681.8M → $1,030M · 5.3%
Asia Pacific$622.5M → $986.4M · 5.9%
Latin America$385.3M → $635.9M · 6.5%
Middle East and Africa$296.4M → $533.3M · 7.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.292026
6.322027
6.322028
6.352029
6.362030
6.352031
6.372032
6.392033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer AG18.8
- Pfizer Inc.15.9
- Nature's Bounty Co.12.8
- GNC Holdings Inc.11.2
- Amway Corporation6.3
- Herbalife Nutrition Ltd.7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form17.5%
Vitamin Type24.9%
Target Consumer25.3%
Distribution Channel16.4%
Price Range15.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.1
- Europe21.3
- Asia Pacific20.4
- Latin America13.2
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer AG | 88 | 91 | 96 | 99 | 83 | 84 | 90 |
| Pfizer Inc. | 80 | 86 | 89 | 93 | 93 | 82 | 87 |
| Nature's Bounty Co. | 70 | 65 | 68 | 66 | 82 | 85 | 73 |
| GNC Holdings Inc. | 73 | 64 | 79 | 77 | 57 | 59 | 68 |
| Amway Corporation | 56 | 62 | 66 | 52 | 76 | 57 | 62 |
| Herbalife Nutrition Ltd. | 61 | 63 | 62 | 47 | 62 | 64 | 60 |
| Abbott Laboratories | 59 | 61 | 60 | 52 | 55 | 51 | 56 |
| Nestlé S.A. | 58 | 46 | 52 | 50 | 57 | 39 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer AG
- Pfizer Inc.
- Nature's Bounty Co.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer AG | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Pfizer Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Nature's Bounty Co. | ◐ | ◐ | ◐ | − | ◐ | ✓ |
| GNC Holdings Inc. | ✓ | ✓ | ◐ | ◐ | ◐ | − |
| Amway Corporation | ◐ | − | ◐ | ◐ | ✓ | ◐ |
| Herbalife Nutrition Ltd. | ◐ | ◐ | ◐ | − | − | − |
| Abbott Laboratories | ◐ | ✓ | − | − | − | ◐ |
| Nestlé S.A. | − | ◐ | − | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer AG90
2Pfizer Inc.87
3Nature's Bounty Co.73
4GNC Holdings Inc.68
5Amway Corporation62
6Herbalife Nutrition Ltd.60
7Abbott Laboratories56
8Nestlé S.A.50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bayer AGPfizer Inc.
Challenger2
Strong scale, closing on the leaders.
Nature's Bounty Co.GNC Holdings Inc.
Contender2
Focused players with pockets of strength.
Amway CorporationHerbalife Nutrition Ltd.
Niche2
Specialists in a single segment or region.
Abbott LaboratoriesNestlé S.A.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Adults' Vitamin Tablets Market — a $372M beachhead inside a $7.15B market.
Beachhead (SOM)$372Mobtainable near-term
Serviceable (SAM)$2.62Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Tablet
Best fit — highest urgency & budget in Product Form.
Economic buyer79 fit
Capsule
Strong fit — clear ROI and a fast path to value.
End user69 fit
Softgel
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Vitamin Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Consumer
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Adults' Vitamin Tablets Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified23%
Evaluation12%
Closed-won8%
$8.6KCAC
$45KLTV
5.2:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Adults' Vitamin Tablets Market is a high-growth opportunity — $6.91B by 2033, compounding at 11.5%.
TAM · 2025$2.89Btoday
TAM · 2033$6.91Bforecast
CAGR11.5%2027–2033
Cumulative$41.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.91BTotal addressable market
SAM$2.43BServiceable available market
SOM$491MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.91BLarge & growingTAM by 2033 at 11.5% CAGR
$2.43BServiceable nowreachable with today’s model
$491MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.39BBear7.5% CAGR
$6.91BBase11.5% CAGR
$8.85BBull15.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Vitamin Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Adults' Vitamin Tablets Market — a $5.19B market by 2033. Plan: grow share from 7.3% to 13.5%.
Market size · 2033$5.19Btotal addressable
Market CAGR7.2%2027–2033
Target share13.5%from 7.3% today
Revenue ambition$700Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 13.5% | On track |
| Revenue | $391M | $700M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.8% | 45.8% | On track |
| Customer retention | 89.9% | 92.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Vitamin Type capability
A defensible second engine — invest in Vitamin Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Vitamin Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $82M capacity & capability investment
- Greenlight bolt-on M&A in Vitamin Type
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Adults' Vitamin Tablets Market conversation — a $10.3B market you can size, segment and defend in minutes.
Market size · 2033$10.3Btotal opportunity
Growth10.9%CAGR to 2033
Addressable buyers1,346+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 4 mopayback period
$42K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Bayer AGPfizer Inc.Nature's Bounty Co.GNC Holdings Inc.Amway CorporationHerbalife Nutrition Ltd.Abbott LaboratoriesNestlé S.A.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Adults' Vitamin Tablets Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Adults' Vitamin Tablets Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Advance Composites Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportAdvance Fiber Market
Market size, share, segmentation and regional forecast.
$899M market · 2025 base year
View reportAdvance Material Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportAdvance Renal Cell Carcinoma Therapeutics Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportAdvance Wound Care Management Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportAdvanced (3D or 4D) Visualization Systems Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportAdvanced Advertising Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAdvanced Air Mobility (AAM) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportAdvanced Airborne Sensor Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAdvanced and Predictive Analytics Software Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportAdvanced and Targeted Drug Delivery Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportAdvanced Battery Energy Storage Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.